Lupin-Natco get USFDA nod to market generic hypertension drug
The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement.
from Moneycontrol Business News http://bit.ly/2ZDtkjQ
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc
Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch
The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement.
Comments
Post a Comment